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First X-ray structural characterisation of host-guest interactions in tetra-tetrazole 
macrocycles  
 
 
Andrew D. Bond, Adrienne Fleming, Jackie Gaire, Fintan Kelleher, John McGinley and Vickie 
McKee.  
 
 
 
The syntheses of tetra-tetrazole macrocycles, containing two 1,3-bis(tetrazole)benzene units linked 
by a variety of n-alkyl (n = 3, 5, 7 or 9 carbon atoms) chain lengths, are described. A tetra-tetrazole 
macrocycle has also been structurally characterised and contains an unexpected “host-guest” 
interaction through binding of a chloroform solvent molecule.  
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Abstract 
 
The syntheses of tetra-tetrazole macrocycles, containing two 1,3-bis(tetrazole)benzene units linked 
by a variety of n-alkyl (n = 3, 5, 7 or 9 carbon atoms) chain lengths, are described. The crystal 
structures of two 1,3-bis(tetrazole)benzenes containing pendant bromoalkyl chains (n = 3 or 5) are 
reported. A tetra-tetrazole macrocycle has also been structurally characterised and contains an 
unexpected “host-guest” interaction through binding of a chloroform solvent molecule. The 
resulting deviation of the macrocycle from planarity results from a combination of the “host-guest” 
interaction and strong intermolecular interactions between adjacent tetrazole and phenylene rings. 
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Introduction 
 
Macrocyclic and macroacyclic compounds have attracted much attention over the past number of 
years due to their role in understanding molecular processes that occur, for example, in 
biochemistry, catalysis and material science. The reviews by Vigato et al. describe the recent 
publications relating to these compounds.
1-3
 The basis for the design of dinucleating or 
polynucleating ligands is the ability of ligands to bind different metal ions. Numerous macrocyclic 
systems exist which contain nitrogen donor atoms, either as a pyridine, imidazole or pyrrole group, 
or as an amine group.
1-8
 However, it is somewhat surprising the relative paucity of macrocycles 
containing tetrazole groups,
9
 considering that there are many articles and reviews on tetrazoles in 
the literature, including their use as the carboxylic acid bioisosteres in drug discovery.
10-12
 The 
development of “click” chemistry methodology, as described by Sharpless and co-workers,13,14 has 
resulted in a recent increase in tetrazole structures, which suggests that molecular recognition 
studies of tetrazoles will become increasing important.
15-21
 Our interest in tetrazoles concerns their 
use as precursors for the formation of new functionalised polytetrazole macrocycles, which can find 
application, for example, as sensors or in molecular recognition. We have previously reported the 
addition of pendant short-chain alkyl halides and vinyl arms to various bistetrazoles, as well as the 
synthesis and structural characterisation of tetra-tetrazole macrocycles from 1,2-, 1,3- and 1,4-
dicyanobenzene derivatives, using short four-carbon, medium six-carbon and long eight-carbon 
alkyl linkers.
22-25
 This paper focuses on the synthesis and characterisation of bis-tetrazoles, from 
1,3-dicyanobenzene, having pendant n-alkyl halide arms (where n = 3, 5, 7 or 9), and their resulting 
tetra-tetrazole macrocycles (Scheme 1). The  X-ray crystal structures of the 1,3-benzene derivatives 
with 3- and 5-carbon chain linkers are described, as is the first example of a host-guest interaction 
between a tetra-tetrazole macrocycle and a solvent molecule. 
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Scheme 1. Reaction conditions: i) 1,n-dibromoalkane (n = 3, 5, 7 or 9), triethylamine, methanol, , 
24 h; ii) 1, potassium carbonate, dimethylformamide, 75°, 24 h. 
 
Results and Discussion 
 
The reactions of 1,3-bis[tetrazol-5-yl]benzene (1) with triethylamine and 1,n-dibromoalkanes (n = 
3, 5, 7 or 9) were carried out in a manner similar to that previously reported.
24
 An excess of the 
dibromoalkane and base was used in order to eliminate any mono-alkyl halide by-products which 
may have been formed. The symmetric 2-N,2-N’-bistetrazole was the major product in all cases. 
The other products in the reactions were not isolated due to the small quantities involved. The 
1
H 
and 
13
C NMR spectra of the unpurified reaction materials showed that the symmetric 2-N,2-N’-
bistetrazole predominated over the asymmetric 1-N,2-N’-bistetrazole in an 85:15 ratio. The mass 
balance of the reaction was the starting bistetrazole (1) which accounted for approximately 60% in 
all cases. Two trends were observed for all the 1,3-bistetrazoles with pendant alkyl halide arms, 
namely an increase in Rf value as the chain length increased and a decrease in melting point as the 
chain length increased (see Figure 1). We have noticed this decrease in melting point for the 
bistetrazole compounds containing even chain length pendant alkyl halide arms (ethyl – octyl), 
although the even cases are slightly higher.
26,27
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Figure 1. Graph showing increase in Rf value in 70:30 petroleum ether:ethyl acetate () and 
decrease in melting point () with increasing alkyl chain length. Best-fit lines through the two sets 
of points give: Rf = (0.0495  no. C atoms) + 0.2705; M.p. = (-5.15  no. C atoms) + 77.9. 
 
Butler and co-workers have described the synthesis of tetra-tetrazole macrocycles, based on either 
1,2- or 1,3-bis(tetrazol-5-yl)benzenes, with alkyl chains having either six or eight carbon chain 
linkers.
28-30
 We have extended this class of compounds by preparing macrocycles with four-carbon 
chain linkers, and also new macrocycles based on 1,4-bis(tetrazol-5-yl)benzene,
22
 by reacting 1,x-
[bis(2-(y-bromoalkyl)tetrazol-5-yl]benzene (x = 2, 3 or 4; y = 4, 6 or 8; alkyl = n-butyl, n-hexyl or 
n-octyl) with 1,n-bis(tetrazol-5-yl)benzene (n = 2, 3 or 4) in dimethylformamide, using K2CO3 as 
base. The tetra-tetrazole molecule synthesised from 1,3-[bis(2-(6-bromohexyl)tetrazol-5-yl]benzene 
and 1,3-bis(tetrazol-5-yl)benzene (1) resulted in a macrocycle containing an internal cavity size of 
10.8 x 9.4 Å. We have now reacted 1,3-[bis(2-(n-bromoalkyl)tetrazol-5-yl]benzene (n = 3, 5, 7 and 
9) and 1,3-bis(tetrazol-5-yl)benzene in a similar manner. The yields for the cyclisation reactions 
were in the range 18-50%, with the highest yield obtained for the macrocycle containing the short 
n-propyl chain. As the chain length increased, the resulting yield decreased, as expected, since the 
entropy of activation is responsible for the difficulty in closing rings larger than six-membered.
31
 
The cyclisation reaction, in all cases, formed predominantly the symmetric product, where the alkyl 
chains are joined to the tetrazole moieties at the 2-N position, with very little asymmetry being 
observed. In the 
1
H NMR spectra of all the cyclisation products, the signal for the CH2Br at ~3.5 
ppm disappeared, and the accompanying loss of the CH2Br signal in the 
13
C NMR spectra 
confirmed that cyclisation had occurred. The simplicity of all the spectra indicated in all cases that 
only a symmetric cyclisation product was obtained, as additional signals would have been expected 
if any asymmetric product had been formed. 
 6 
 
X-Ray Crystal Structures 
 
Crystals of compounds 2 and 3, suitable for an X-Ray diffraction study, were obtained from 
chloroform solution and the structures confirmed the presence of the pendant bromoalkyl groups at 
the 2-N, 2-N'-positions for 2 and 3 (Figures 2 and 3). We have previously published the crystal 
structure of 1,3-bis[(2-bromoethyl)tetrazol-5-yl]benzene (10),
24
 and a second polymorph of that 
compound has also been published (denoted 10a).
32
  
 
 
 
Figure 2. Molecular structure of 2 with displacement ellipsoids at the 50% probability level for 
non-H atoms. The N3–C9 and N7–C12 bonds form an obtuse angle. 
 
 
 
Figure 3. Molecular structure of 3 with displacement ellipsoids at the 50% probability level for 
non-H atoms. A crystallographic 2-fold axis passes through atoms C1 and C4. The N3–C9 and N7–
C12 bonds form an acute angle. 
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In 2 and 3, the tetrazole rings are close to coplanar with the benzene ring to which they are attached, 
and the bromoalkyl groups project to either side of this plane. This feature of the molecular 
conformation is similar to 10a, while the bromoalkyl groups project to the same side of the 
molecular plane in the polymorph 10. In 3, 10 and 10a, the substituted 2-N atoms point in the same 
direction so that the two N-CH2 bond vectors form an acute angle (see Figure 3). The conformation 
of 2 is distinct in that one tetrazole ring is flipped over with respect to the molecular plane so that 
the two N-CH2 bond vectors form an acute angle (see Figure 2). In 3 and 10a, the molecules lie on 
crystallographic 2-fold axes, while in 10 they display approximate (non-crystallographic) mirror 
symmetry. 
 
The structures of 2 and 3 contain similar 2-D layers (Figures 4 and 5). The central sections of the 
molecules approach each other in a side-on manner, forming 1-D motifs along the b direction. Thus, 
the length of the b axis is closely comparable in the two crystal structures. In both cases, the 1-D 
motifs are arranged in an anti-parallel manner, with adjacent molecules forming slipped -stacked 
arrangements. The perpendicular distance between molecular planes is 3.37(1) Å in 2 and 3.21(1) Å 
in 3, and the centroid-centroid distances for interacting phenylene rings are 4.684 and 6.013 Å in 2, 
and 5.409 and 6.104 Å in 3.  
 
 
 
Figure 4. Projection of the crystal structure of 2 along the a axis, showing the layered structure with 
“Type II” Br···Br contacts between layers. H atoms are omitted. 
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Figure 5. Projection of 3 along the c axis, showing the layered structure with “Type I” Br···Br 
contacts between layers. H atoms are omitted. 
 
In 3, adjacent 2-D layers meet so as to bring the terminal CH2Br bonds into an offset co-linear 
alignment (Figure 5), forming “Type I” BrBr interactions, as classified previously by Desiraju et 
al.
33
 The intermolecular Br

Br distance is 3.489(2) Å, which is considerably shorter than twice the 
bromine van der Waals radius (3.90 Å) and within the range of those values previously reported, 
3.415–3.691 Å.23,34-36 In 2, the BrBr interactions resemble side-on “Type II” interactions, with a 
shortest distance of 3.771(3) Å. 
 
Crystals of 7 were obtained from chloroform solution, and the crystal structure confirms the 
expected tetra-tetrazole macrocyclic structure, with each tetrazole ring substituted at the 2-N 
position, as suggested by 
13C NMR spectroscopy. The structure also reveals an unexpected “host-
guest” interaction between the macrocycle and a molecule of chloroform solvent (Figure 6). The 
molecule lies on a crystallographic 2-fold rotation axis, and the CHCl3 molecule is disordered 
equally over two orientations about this axis, forming CH interactions in which the H atom 
lies 2.50 Å above the mean plane of the phenylene ring. The interaction and encapsulation of the 
CHCl3 molecule is facilitated by a bowl-shaped conformation of the tetra-tetrazole macrocycle, 
which is distinctly different from the essentially flat structure that we have reported for a similar 
six-carbon linked macrocycle for which no solvent is present.
22
 The molecules of 7 are stacked in 
columns parallel to the b axis (see Figure 7) with  stacking interactions between neighbouring 
tetrazole and phenylene rings (centroid-centroid distance 3.694 Å. Similar interactions have been 
observed in other tetrazole structures.
22-25
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Figure 6. Molecular structure of 7 with displacement ellipsoids at the 50% probability level for 
non-H atoms. The CHCl3 molecule is disordered about a crystallographic 2-fold rotation axis; atoms 
with suffix A are generated by the symmetry operator –x, y, ½-z. Dashed lines represent C–H···π 
interactions. 
 
 
Figure 7. Partial packing diagram of 7 showing the bowl-shaped macrocycles stacked in columns 
along the b axis. Both orientations of the disordered CHCl3 molecule are shown. H atoms are 
omitted. 
 
Conclusions 
 10 
 
In this paper, we have reported on the syntheses and characterisation of bromo-alkyl derivatives of 
1,3-bis(tetrazole)benzene, where the alkyl chain contains either 3, 5, 7 or 9 carbons atoms. 
Interestingly, the predominant compound formed in all these reactions is the symmetric 2-N,2-N’-
bistetrazole isomer, whereas the same reactions carried out with even n-alkyl chains have 
previously yielded both symmetric 2-N,2-N’-bistetrazole and asymmetric 1-N,2-N’-bistetrazole 
derivatives. Four new macrocycles containing four tetrazole rings were synthesised and the X-ray 
crystal structure of 7 showed a bowl-shaped conformation with an interesting host-guest interaction 
with an encapsulated solvent chloroform molecule. 
 
Experimental 
 
1
H and 
13
C NMR (δ ppm; J Hz) spectra were recorded on a JEOL JNM-LA300 FT-NMR 
spectrometer using saturated CDCl3 solutions with Me4Si reference, unless indicated otherwise, 
with resolutions of 0.18 Hz and 0.01 ppm, respectively. Infrared spectra (cm
-1
) were recorded as 
KBr discs or liquid films between KBr plates using a Nicolet Impact 410 FT-IR. Melting point 
analysis was carried out using a Stewart Scientific SMP 1 melting point apparatus and are 
uncorrected. Mass spectra were obtained from the CSCB Mass Spectrometry Centre, School of 
Chemistry and Chemical Biology, University College Dublin using a Micromass/Waters Corp. 
Liquid chromatography time-of-flight (LCT) mass spectrometer equipped with an electrospray 
source. Microanalysis was carried out at the Microanalytical Laboratory of University College, 
Dublin. Standard Schlenk techniques were used throughout. Starting materials were commercially 
obtained and used without further purification. The synthesis of compound 1 has been described in 
the literature previously.
24
  
 
General Syntheses of 1,n-bis(bromoalkyltetrazolyl)benzenes 
 
Compound 1 (1.0 g, 0.47 mmol) was dissolved in methanol (30 ml) and, to the stirred solution, was 
added triethylamine (3.0 ml, 2.8 mmol). The resulting solution was heated to reflux for 30 min, and 
to the hot solution was added 1,n-dibromoalkane (1.4 mmol). The reaction mixture was then heated 
to reflux for a further 24 hours. After cooling, the solvent was removed under reduced pressure to 
afford an oil which was then purified by column chromatography on silica gel (initially at the ratio 
of petroleum ether:ethyl acetate 80:20, followed by the ratio 60:40). 
 
1,3-Bis[(3-bromoproyl)tetrazol-5-yl]benzene (2-N, 2-N’) (2) 
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White solid. Analysis: Found: C, 37.12; H, 3.58; N, 24.41. Calc. For C14H16N8Br2: C, 36.86; H, 
3.54; N, 24.57; Yield: 0.32 g, 16 %, 0.70 mmol; Rf 0.43 (70:30 petroleum ether:ethyl acetate); M.p. 
62–64 C; νmax (KBr) 3421, 2919, 2847, 1623, 1521, 1455, 1347, 1276, 1194, 1086, 799, 743 cm
-1
; 
H : 2.65 (m, 4 H, CH2), 3.49 (t, 4 H, J = 6.8 Hz, CH2Br), 4.88 (t, 4 H, J = 5.6 Hz, tetrazole N2-
CH2), 7.64 (t, 1 H, J = 7.9 Hz, Ar-H), 8.29 (dd, 2 H, J = 7.6, 1.2 Hz, Ar-H), 8.92 (s, 1 H, Ar-H); C : 
29.0, 31.0 (CH2Br), 51.0 (tetrazole N2-CH2), 125.2, 128.0, 128.1, 129.0, 164.0 (2,5-tetrazole). 
 
1,3-Bis[(5-bromopentyl)tetrazol-5-yl]benzene (2-N, 2-N’) (3) 
 
White solid. Analysis: Found: C, 42.46; H, 4.77; N, 21.74. Calc. For C18H24N8Br2: C, 42.40; H, 
4.72; N, 21.88; Yield: 0.32 g, 18 %, 0.62 mmol; Rf 0.50 (70:30 petroleum ether:ethyl acetate); M.p. 
51–52 C; νmax (KBr) 3448, 2956, 2922, 2851, 1638, 1513, 1456, 1430, 1385, 1271, 1196, 1048, 
904, 799, 740, 689, 638 cm
-1
; H : 1.55 (m, 4 H, CH2), 1.86 (m, 4 H, CH2), 2.01 (m, 4 H, CH2), 3.41 
(t, 4 H, J = 6.4 Hz, CH2Br), 4.70 (t, 4 H, J = 7.6 Hz, tetrazole N2-CH2), 7.63 (t, 1 H, J = 7.6 Hz, Ar-
H), 8.24 (dd, 2 H, J = 7.6, 1.2 Hz, Ar-H), 8.92 (s, 1 H, Ar-H); C : 24.8, 28.3, 31.7, 32.9 (CH2Br), 
52.8 (tetrazole N2-CH2), 125.0, 128.3, 128.5, 129.4, 164.0 (2,5-tetrazole). 
 
1,3-Bis[(7-bromoheptyl)tetrazol-5-yl]benzene (2-N, 2-N’) (4) 
 
White solid. Analysis: Found: C, 46.38; H, 5.69; N, 19.45. Calc. For C22H32N8Br2: C, 46.49; H, 
5.67; N, 19.72; Yield: 0.32 g, 12 %, 0.56 mmol; Rf 0.62 (70:30 petroleum ether:ethyl acetate); M.p. 
41-42 C; νmax (KBr) 3430, 3016, 2934, 2858, 1625, 1521, 1455, 1347, 1214, 1040, 932, 800, 753, 
671 cm
-1
; H : 1.55 (m, 12 H, CH2), 1.88 (m, 4 H, CH2), 2.09 (m, 4 H, CH2), 3.38 (t, 4 H, J = 5.9 
Hz, CH2Br), 4.68 (t, 4 H, J = 5.9 Hz, tetrazole N2-CH2), 7.63 (t, 1 H, J = 8.1 Hz, Ar-H), 8.27 (dd, 2 
H, J = 7.6, 1.2 Hz, Ar-H), 8.93 (s, 1 H, Ar-H); C : 26.1, 27.7, 29.1, 32.5, 33.7 (CH2Br), 53.1 
(tetrazole N2-CH2), 125.1, 128.2, 128.4, 129.4, 164.0 (2,5-tetrazole). 
 
1,3-Bis[(9-bromononyl)tetrazol-5-yl]benzene (2-N, 2-N’) (5) 
 
White solid. Analysis: Found: C, 50.18; H, 6.46; N, 16.91. Calc. For C26H40N8Br2: C, 50.01; H, 
6.46; N, 17.94; Yield: 0.61 g, 21.3 %, 0.98 mmol; Rf 0.72 (70:30 petroleum ether:ethyl acetate); 
M.p. 31–33 C; νmax (KBr) 3442, 2919, 2849, 1654, 1526, 1455, 1347, 1256, 1191, 1082, 788, 742, 
723, 683, 648 cm
-1
; H : 1.37 (m, 20 H, CH2), 1.84 (m, 4 H, CH2), 2.08 (m, 4 H, CH2), 3.39 (t, 4 H, 
 12 
J = 6.3 Hz, CH2Br), 4.67 (t, 4 H, J = 5.9 Hz, tetrazole N2-CH2), 7.63 (t, 1 H, J = 7.9 Hz, Ar-H), 
8.27 (dd, 2 H, J = 7.6, 1.2 Hz, Ar-H), 8.94 (s, 1 H, Ar-H); C : 26.2, 28.1, 28.5, 28.7, 29.1, 29.3, 
32.2, 34.0 (CH2Br), 53.2 (tetrazole N2-CH2), 125.1, 128.2, 128.4, 129.4, 164.0 (2,5-tetrazole). 
 
General Syntheses of tetra-tetrazolophanes 
 
A mixture of 1 (240 mg, 1.1 mmol) and potassium carbonate (1.5 g, 11 mmol) in 
dimethylformamide (60 ml) was stirred for one hour at 75 C under an nitrogen atmosphere, and 
then treated with the appropriate 1,n-bis(bromoalkyltetrazolyl)benzene (2-5, 1.1 mmol) and stirred 
at 75 C for 24 h. Insoluble salts, filtered from the cooled mixture, were washed with ethyl acetate 
and the combined washings and mother-liquor were evaporated under reduced pressure. The white 
residue which remained was dissolved in chloroform and chromatographed on silica gel using 
DCM:MeOH (99.5:0.5 to 99.0:1.0 v/v) as eluent to give the tetra-tetrazolophane macrocycle. 
 
Di-metabenzenotetra(5', 2'-tetrazolo)[5'-(2)-2'-(3)]-cyclophane (2-N, 2-N', 2-N'', 2-N''') (6). 
 
White solid. Analysis: Found: C, 51.83; H, 4.01; N, 44.17. Calc. For C22H20N16: C, 51.96; H, 3.96; 
N, 44.07; Yield: 0.28 g, 50.0 %, 0.55 mmol; Rf 0.14 (40:60 petroleum ether:ethyl acetate); M.p. 
>300 C; νmax (KBr) 3439, 2927, 2852, 1637, 1515, 1455, 1432, 1357, 1214, 1088, 1047, 920, 786, 
746, 691 cm
-1
; H : 2.18 (m, 4 H, CH2), 4.68 (t, 8 H, J = 6.9 Hz, NCH2), 7.63 (t, 2 H, J = 7.9 Hz, Ar-
H), 8.27 (d, 4 H, J = 7.9 Hz, Ar-H), 8.72 (s, 2 H, Ar-H); C : 22.9, 29.0, 52.6 (tetrazole N2-CH2), 
126.3, 128.0, 128.5, 129.6, 164.4 (2,5-tetrazole); HRMS (ES) Calc. [M+1] 509.502, Found 509.504.  
 
Di-metabenzenotetra(5', 2'-tetrazolo)[5'-(2)-2'-(5)]-cyclophane (2-N, 2-N', 2-N'', 2-N''') (7). 
 
White solid. Analysis: Found: C, 55.65; H, 5.09; N, 39.47. Calc. For C26H28N16: C, 55.31; H, 5.00; 
N, 39.69; Yield: 0.25 g, 40.0 %, 0.44 mmol; Rf 0.35 (40:60 petroleum ether:ethyl acetate); M.p. 
>300 C; νmax (KBr) 3435, 2927, 2852, 1647, 1523, 1455, 1432, 1390, 1357, 1214, 1088, 1047, 820, 
786, 746, 690 cm
-1
; H : 1.25 (m, 4 H, CH2), 2.23 (m, 8 H, CH2), 4.69 (t, 8 H, J = 6.8 Hz, NCH2), 
7.61 (t, 2 H, J = 7.9 Hz, Ar-H), 8.27 (d, 4 H, J = 7.9 Hz, Ar-H), 8.72 (s, 2 H, Ar-H); C : 22.9, 28.7, 
29.7, 52.6 (tetrazole N2-CH2), 125.8, 127.9, 128.4, 129.5, 164.6 (2,5-tetrazole); HRMS (ES) Calc. 
[M+1] 565.608, Found 565.273. 
 
Di-metabenzenotetra(5', 2'-tetrazolo)[5'-(2)-2'-(7)]-cyclophane (2-N, 2-N', 2-N'', 2-N''') (8). 
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White solid. Analysis: Found: C, 58.35; H, 6.11; N, 35.88. Calc. For C30H36N16: C, 58.05; H, 5.85; 
N, 36.10; Yield: 0.14 g, 20 %, 0.23 mmol; Rf 0.49 (40:60 petroleum ether:ethyl acetate); M.p. 258-
260 C; νmax (KBr) 3423, 2922, 2853, 1648, 1523, 1452, 1430, 1384, 1357, 1214, 1088, 1045, 912, 
781, 746, 692 cm
-1
; H : 0.80 (m, 8 H, CH2), 1.18 (m, 4 H, CH2), 2.02 (m, 8 H, CH2), 4.59 (t, 8 H, J 
= 6.6 Hz, NCH2), 7.51 (t, 2 H, J = 7.9 Hz, Ar-H), 8.17 (d, 4 H, J = 7.9 Hz, Ar-H), 8.77 (s, 2 H, Ar-
H); C : 22.7, 26.0, 29.7, 53.1 (tetrazole N2-CH2), 125.7, 128.2, 128.4, 129.5, 164.5 (2,5-tetrazole); 
HRMS (ES) Calc. [M+1] 621.330, Found 621.332. 
 
Di-metabenzenotetra(5', 2'-tetrazolo)[5'-(2)-2'-(9)]-cyclophane (2-N, 2-N', 2-N'', 2-N''') (9). 
 
White solid. Analysis: Found: C, 60.43; H, 6.62; N, 33.15. Calc. For C34H44N16: C, 60.34; H, 6.55; 
N, 33.11; Yield: 0.14 g, 18 %, 0.21 mmol; Rf 0.75 (40:60 petroleum ether:ethyl acetate); M.p. 206-
209 C; νmax (KBr) 3423, 2925, 2851, 1637, 1536, 1458, 1432, 1261, 1088, 1045, 810, 743, 688 cm
-
1
; H : 1.54 (m, 20 H, CH2), 2.13 (m, 8 H, CH2), 4.72 (t, 8 H, J = 6.6 Hz, NCH2), 7.65 (t, 2 H, J = 
7.9 Hz, Ar-H), 8.22 (d, 4 H, J = 7.9 Hz, Ar-H), 8.95 (s, 2 H, Ar-H); C : 26.7, 27.3, 28.6, 30.1, 52.1 
(tetrazole N2-CH2), 126.8, 128.1, 128.3, 129.5, 164.0 (2,5-tetrazole); HRMS (ES) Calc. [M+1] 
677.393, Found 677.401. 
 
X-Ray Crystallography 
Crystals of 2, 3 and 7 suitable for X-ray analysis, were obtained by recrystallisation from 
chloroform solution. Data for 2 and 3 were collected on a Bruker Nonius X8 APEXII 
diffractometer
37
 at 180(2) K and 298(2) K, respectively, and data for 7 were collected at 150(2) K 
on a Bruker APEXII diffractometer. In each case Mo-Kα radiation ( = 0.71073 Å) was used, a 
multi-scan correction was applied
38
 and the structure was refined against F
2
 using all data. All non-
hydrogen atoms were refined with anisotropic atomic displacement parameters and hydrogen atoms 
were placed at calculated positions and refined using a riding model.   
 
Compound 2. Crystal data: C14H16Br2N8, M = 456.17, triclinic, a = 7.0009(4), b = 7.1694(4), c = 
17.5789(10) Å, α = 100.518(2),  = 92.790(2), γ = 92.019(2), U = 865.60(5) Å3, space group P-1, 
Z = 2, μ = 4.697 mm-1, calc = 1.750 g cm
–3
. 33334 data (3891 unique, Rint = 0.0285) were measured 
in the range 3.54 < θ < 28.34˚. R1(I > 2σ(I)) = 0.0312 and wR2(all data) = 0.0863. Goodness of fit on 
F
2
 = 1.06. CCDC No. 725917. 
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Compound 3. Crystal data: C18H24Br2N8, M = 512.27, monoclinic, a = 34.3306(7), b = 7.0548(1), 
c = 9.0546(2) Å,  = 102.433(1), U = 2141.55(7) Å3, space group C 2/c, Z = 4, μ = 3.806 mm-1, 
calc = 1.589 g cm
–3
. 8687 data (2034 unique, Rint = 0.0232) were measured in the range 3.65 < θ < 
25.73˚. R1(I > 2σ(I)) = 0.0328 and wR2(all data) = 0.0827. Goodness of fit on F
2
 = 1.03. CCDC No. 
725918. 
 
Compound 7. Crystal data: C27H29Cl3N16, M = 684.01, monoclinic, a = 24.584(3), b = 6.5069(8), c 
= 22.926(3) Å,  = 119.469(2), U = 3192.9(6) Å3, space group C 2/c, Z = 4, μ = 0.335 mm-1, calc = 
1.423 g cm
–3
. 13630 data (3282 unique, Rint = 0.0472) were measured in the range 1.90 < θ < 
26.45˚. R1(I > 2σ(I)) = 0.0426 and wR2(all data) = 0.1213. Goodness of fit on F
2
 = 0.937. CCDC 
No. 725395. 
 
Supplementary material 
 
Crystallographic data for 2, 3 and 7 have been deposited with the Cambridge Crystallographic Data 
Centre, CCDC Nos. 725917, 725918 and 725395. Copies of this information may be obtained free 
of charge from deposit@ccdc.cam.ac.uk or www:http://www.ccdc.cam.ac.uk 
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